Rocket Pharmaceuticals Inc (RCKT)
22.71
-0.73
(-3.11%)
USD |
NASDAQ |
Apr 19, 16:00
22.71
0.00 (0.00%)
After-Hours: 20:00
Rocket Pharmaceuticals Cash from Investing (TTM): -98.07M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -98.07M |
| September 30, 2023 | -65.85M |
| June 30, 2023 | -90.64M |
| March 31, 2023 | -43.05M |
| December 31, 2022 | -69.33M |
| September 30, 2022 | 56.12M |
| June 30, 2022 | 14.47M |
| March 31, 2022 | -14.97M |
| December 31, 2021 | 18.85M |
| September 30, 2021 | -52.47M |
| June 30, 2021 | -98.48M |
| March 31, 2021 | -153.26M |
| December 31, 2020 | -96.59M |
| September 30, 2020 | -18.62M |
| June 30, 2020 | 80.76M |
| March 31, 2020 | -40.69M |
| December 31, 2019 | -39.01M |
| Date | Value |
|---|---|
| September 30, 2019 | -43.48M |
| June 30, 2019 | -81.64M |
| March 31, 2019 | -62.18M |
| December 31, 2018 | -5.272M |
| September 30, 2018 | 51.42M |
| June 30, 2018 | 54.41M |
| March 31, 2018 | 161.22M |
| December 31, 2017 | 75.02M |
| September 30, 2017 | -43.01M |
| June 30, 2017 | -38.08M |
| March 31, 2017 | -53.85M |
| December 31, 2016 | -66.06M |
| September 30, 2016 | -26.02M |
| June 30, 2016 | -60.35M |
| March 31, 2016 | -44.02M |
| December 31, 2015 | -31.68M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-153.26M
Minimum
Mar 2021
80.76M
Maximum
Jun 2020
-44.00M
Average
-43.48M
Median
Sep 2019
Cash from Investing (TTM) Benchmarks
| ADMA Biologics Inc | -4.981M |
| Geron Corp | -180.32M |
| Madrigal Pharmaceuticals Inc | -502.52M |
| Ligand Pharmaceuticals Inc | -11.68M |
| Puma Biotechnology Inc | -19.12M |